Skip to main content
Jason Beaver, MD, General Surgery, Dothan, AL

Jason D. Beaver MD


Physician

Join to View Full Profile
  • 2800 Ross Clark CirSte 2Dothan, AL 36301

  • Phone+1 334-305-1848

  • Fax+1 334-305-1849

Dr. Beaver is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Jason Beaver is a general surgeon based in Dothan, AL, with expertise in general and vascular surgery. He completed his medical education at the University of Florida College of Medicine in 1996 and his surgery residency at USA Health in 2001. Dr. Beaver has contributed to several publications in vascular access and has been involved in clinical trials, such as the evaluation of a vascular venous anastomotic connector. He has received multiple CMS Meaningful Use Stage 1 and Stage 2 Certifications from various organizations.

Education & Training

  • USA Health
    USA HealthResidency, Surgery, 1996 - 2001
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 1996

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1997 - 2026
  • FL State Medical License
    FL State Medical License 2001 - 2023
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2013-2015, 2017
  • CMS Meaningful Use Stage 1 Certification WellCentive Registry, Wellcentive, Inc., 2013-2015, 2017
  • CMS Meaningful Use Stage 2 Certification HealthGrid Collaboration Platform, Health Grid Corp, 2013-2015, 2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity® Percutaneous AVF System
    Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity® Percutaneous AVF SystemNovember 6th, 2025
  • VENOS-3 Pivotal Study Begins for Venova’s Velocity pAVF System
    VENOS-3 Pivotal Study Begins for Venova’s Velocity pAVF SystemNovember 6th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: